Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-099259
Filing Date
2025-07-28
Accepted
2025-07-28 17:15:22
Documents
1
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 19883
  Complete submission text file 0000950170-25-099259.txt   21343
Mailing Address C/O VERVE THERAPEUTICS, INC. 201 BROOKLINE AVENUE, SUITE 601 BOSTON MA 02215
Business Address
Lister Troy (Reporting) CIK: 0002023489 (see all company filings)